Tran, Giao <br/><br/>
Pharmaco-economic analysis of direct medical costs of metastatic colorectal cancer therapy with XELOX or modified FOLFOX-6 regimens: implications for health-care utilization in Australia.  [electronic resource] 

 -  Asia-Pacific journal of clinical oncology  Sep 2013 
 - 239-48 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1743-7563 
<br/><br/><label>Standard No.: </label>10.1111/ajco.12044  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Australia<br/>Capecitabine<br/>Colorectal Neoplasms--drug therapy<br/>Cost-Benefit Analysis<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Leucovorin--administration & dosage<br/>Male<br/>Neoplasm Metastasis<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaloacetates<br/>Randomized Controlled Trials as Topic--economics